Minocycline is a semi-synthetic tetracycline antibiotic that crosses the blood-brain barrier. Minocycline is an inhibitor of hypoxia-inducing factor (HIF-1α). Minocycline has anti-cancer, anti-inflammatory and glutamate antagonism. Minocycline reduces glutamate neurotransmission, showing neuroprotective properties and antidepressant effects. Minocycline inhibits the synthesis of bacterial proteins by binding with the 30S subunit of bacterial ribosomes, thus producing bacteriostatic effect
Specifictaions: Moligand™, ≥98%
MDL Number: C23H27N3O7
Molecular Formula: 457.50
PubChem CID: 54675783
Isomeric SMILES: CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/M611887-SCI_67c760e9842c48872f699facd6ec59bb.pdf
- UPC:
- 51284012
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 1.06 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- M611887-1mg
- CAS:
- 10118-90-8
- Product Size:
- 1mg
- Health Hazards:
- Carcinogen
- Hazard Statement Codes:
- H335;H319;H315
- Precautionary Statement Codes:
- P305+P351+P338;P261
